The Effect of Using the Combat Attention App on the Risk of Post-traumatic Symptoms

April 8, 2025 updated by: Yair Bar-Haim, Tel Aviv University
Military service and reserve duty in combat units entails exposure to traumatic events that require mental adjustment. In light of the results of controlled studies that proved the effectiveness an response-time based mechanized training protocol in reducing risk for post-trauma symptoms in deployed combat soldiers, the Israeli Defense Forces decided at the beginning of the Iron Swords War to implement an internet-based App of the intervention. Soldiers and combat reservists were invited to use the Combat Attention App. The purpose of this study is to examine the effectiveness of the Combat Attention App in relation to a control group of soldiers who did not use the App in reducing risk for post-traumatic stress symptoms of deployed soldiers.

Study Overview

Status

Not yet recruiting

Detailed Description

Participants who used the Combat Attention App before combat deployment and a group of matched (age and sex) participants who did not use the App will be compared on PTSD, depression, and anxiety symptoms post deployment.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tel Aviv, Israel
        • Tel Aviv University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population consists of enlisted and reservist soldiers who participated in the Iron Swards war and either used or did not use the attention App.

Description

Inclusion criteria:

  • Age over 18 years.
  • Served as an enlisted soldier or reservist during the Iron Swards War.
  • Used the Combat Attention App or can serve as a matched control who did not use the App.
  • Colloquial Hebrew sufficient to fill out the research questionnaires.

Exclusion criteria:

  • Below 18 years of age.
  • Colloquial Hebrew that is insufficient to fill out the research questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Attention App Users
Soldiers who used the App and completed at least one training session
The Combat Attention App is a response-time based mechanized preventive intervention designed to train combat soldiers' attention toward threats before combat exposure in order to reduce the risk for combat-related post-trauma symptoms. In light of the results of controlled studies that proved the efficacy of this preventive intervention, the Israel Defense Forces (IDF) decided at the beginning of the Iron Swords War (October 7th, 2023) to implement an internet-based App of the intervention, and soldiers and combat reservists were invited to train on the Combat Attention App.
Non Users
Soldiers matched on age, sex, and specialty to the Attention App Users group who never used the App

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD Checklist for DSM-5 (PCL-5)
Time Frame: January-June 2025
Measures PTSD symptoms according to DSM-5
January-June 2025
IDF Medical Records
Time Frame: January-June 2025
Holds all the medical information and contact with health/mental health professionals during one's service
January-June 2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Combat Experiences Scale
Time Frame: January-June 2025
Measures the occurrence of specific combat events
January-June 2025
Patient Health Questionnaire 9 (PHQ-9)
Time Frame: January-June 2025
Measures Depression symptoms according to DSM-5
January-June 2025
Attention Bias Questionnaire (ABQ)
Time Frame: January-June 2025
Measures subjective experiences of attention allocation to threats
January-June 2025
GAD-7
Time Frame: January-June 2025
measures symptoms of generalized anxiety disorder
January-June 2025
Dissociative Experiences Scale (DES)
Time Frame: January-June 2025
measures dissociative symptoms associated with trauma exposure
January-June 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yair Bar-Haim, PhD, Tel Aviv University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 31, 2024

First Submitted That Met QC Criteria

November 25, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2025

Last Update Submitted That Met QC Criteria

April 8, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • TAU-Combat-Attention

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD - Post Traumatic Stress Disorder

Clinical Trials on Combat Attention Training

Subscribe